Canada’s regulatory approach to drugs for rare diseases: orphan drugs
Canada's regulatory approach: Drugs for rare diseases are authorized for sale in Canada under the Food and Drugs Act and Part C of the Food and Drug Regulations.
- Publisher - Current Organization Name: Health Canada
- Licence: Open Government Licence - Canada
Data and Resources
-
Canada’s regulatory approach to drugs for rare diseases: orphan drugsHTMLEnglish publication HTML
-
Canada’s regulatory approach to drugs for rare diseases: orphan drugsHTMLFrench publication HTML
Similar records